Rank | Gene Set | Z-score |
---|---|---|
1 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.78555050 |
2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.78555050 |
3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.78555050 |
4 | modulation by symbiont of host immune response (GO:0052553) | 6.78555050 |
5 | positive regulation by symbiont of host defense response (GO:0052509) | 6.78555050 |
6 | modulation by symbiont of host defense response (GO:0052031) | 6.78555050 |
7 | neutrophil activation involved in immune response (GO:0002283) | 6.35077751 |
8 | macrophage activation involved in immune response (GO:0002281) | 5.75245818 |
9 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.74522796 |
10 | microglial cell activation (GO:0001774) | 5.37270812 |
11 | positive regulation of interferon-alpha production (GO:0032727) | 5.20283140 |
12 | detection of other organism (GO:0098543) | 5.10675878 |
13 | immunoglobulin mediated immune response (GO:0016064) | 5.06751892 |
14 | regulation of interferon-alpha production (GO:0032647) | 4.90423071 |
15 | respiratory burst (GO:0045730) | 4.86302783 |
16 | * antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.82899709 |
17 | response to peptidoglycan (GO:0032494) | 4.72480963 |
18 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.63572488 |
19 | detection of bacterium (GO:0016045) | 4.62043984 |
20 | detection of external biotic stimulus (GO:0098581) | 4.59201014 |
21 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.55868397 |
22 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.44782811 |
23 | response to host immune response (GO:0052572) | 4.44782811 |
24 | granulocyte activation (GO:0036230) | 4.38113534 |
25 | regulation of gamma-delta T cell activation (GO:0046643) | 4.37294682 |
26 | macrophage activation (GO:0042116) | 4.35948365 |
27 | neutrophil activation (GO:0042119) | 4.32768447 |
28 | myeloid cell activation involved in immune response (GO:0002275) | 4.21674804 |
29 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.13258778 |
30 | positive regulation of antigen processing and presentation (GO:0002579) | 4.12708001 |
31 | detection of biotic stimulus (GO:0009595) | 4.11970567 |
32 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.05546601 |
33 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.00215098 |
34 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.98484260 |
35 | response to host (GO:0075136) | 3.98484260 |
36 | response to host defenses (GO:0052200) | 3.98484260 |
37 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.87598758 |
38 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.86791388 |
39 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.79805317 |
40 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.79391893 |
41 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.79360552 |
42 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.77565276 |
43 | regulation of mononuclear cell migration (GO:0071675) | 3.75902470 |
44 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.74702382 |
45 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.72977956 |
46 | positive regulation of interferon-beta production (GO:0032728) | 3.72530412 |
47 | B cell mediated immunity (GO:0019724) | 3.69066328 |
48 | superoxide anion generation (GO:0042554) | 3.66824128 |
49 | positive regulation of mast cell activation (GO:0033005) | 3.62070735 |
50 | leukocyte aggregation (GO:0070486) | 3.59746891 |
51 | negative regulation of T cell mediated immunity (GO:0002710) | 3.56500332 |
52 | positive regulation of mast cell degranulation (GO:0043306) | 3.54016448 |
53 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.54016448 |
54 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.53696844 |
55 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.51680713 |
56 | reactive oxygen species biosynthetic process (GO:1903409) | 3.51291885 |
57 | regulation of antigen processing and presentation (GO:0002577) | 3.48338654 |
58 | regulation of mast cell degranulation (GO:0043304) | 3.46685418 |
59 | regulation of tolerance induction (GO:0002643) | 3.43563360 |
60 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.41220495 |
61 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.40640275 |
62 | negative regulation of interleukin-17 production (GO:0032700) | 3.37849279 |
63 | regulation of mast cell activation (GO:0033003) | 3.32863195 |
64 | regulation of T cell tolerance induction (GO:0002664) | 3.31223504 |
65 | response to muramyl dipeptide (GO:0032495) | 3.30677337 |
66 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.30099371 |
67 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.29507420 |
68 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.28799099 |
69 | myeloid leukocyte activation (GO:0002274) | 3.28194816 |
70 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.26643875 |
71 | natural killer cell mediated immunity (GO:0002228) | 3.26643875 |
72 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.26084148 |
73 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.24659911 |
74 | I-kappaB phosphorylation (GO:0007252) | 3.24134715 |
75 | detection of molecule of bacterial origin (GO:0032490) | 3.23529207 |
76 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.23076585 |
77 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.22908482 |
78 | B cell receptor signaling pathway (GO:0050853) | 3.18900091 |
79 | cellular extravasation (GO:0045123) | 3.17914800 |
80 | regulation of monocyte chemotaxis (GO:0090025) | 3.17452458 |
81 | leukocyte mediated cytotoxicity (GO:0001909) | 3.14510012 |
82 | myeloid leukocyte mediated immunity (GO:0002444) | 3.13939762 |
83 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.13926224 |
84 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.13359084 |
85 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.13106932 |
86 | type I interferon signaling pathway (GO:0060337) | 3.13003278 |
87 | cellular response to type I interferon (GO:0071357) | 3.13003278 |
88 | myeloid dendritic cell differentiation (GO:0043011) | 3.12755114 |
89 | positive regulation of macrophage cytokine production (GO:0060907) | 3.11303772 |
90 | response to type I interferon (GO:0034340) | 3.09653628 |
91 | cellular response to zinc ion (GO:0071294) | 3.08726314 |
92 | monocyte chemotaxis (GO:0002548) | 3.08394250 |
93 | T-helper 1 type immune response (GO:0042088) | 3.08087805 |
94 | positive regulation of leukocyte degranulation (GO:0043302) | 3.07795007 |
95 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.06819321 |
96 | defense response to protozoan (GO:0042832) | 3.05292077 |
97 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.03922237 |
98 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.03042414 |
99 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.01303269 |
100 | myeloid dendritic cell activation (GO:0001773) | 3.01261685 |
101 | positive thymic T cell selection (GO:0045059) | 3.01147595 |
102 | negative regulation of mast cell activation (GO:0033004) | 3.01136773 |
103 | eosinophil chemotaxis (GO:0048245) | 3.00946741 |
104 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.00418438 |
105 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.99661651 |
106 | positive regulation of B cell differentiation (GO:0045579) | 2.98570500 |
107 | lymphocyte chemotaxis (GO:0048247) | 2.94446034 |
108 | regulation of B cell differentiation (GO:0045577) | 2.94020892 |
109 | phagosome maturation (GO:0090382) | 2.92952654 |
110 | lymphocyte mediated immunity (GO:0002449) | 2.92495641 |
111 | regulation of leukocyte degranulation (GO:0043300) | 2.91834411 |
112 | response to interleukin-15 (GO:0070672) | 2.91734185 |
113 | germinal center formation (GO:0002467) | 2.91305324 |
114 | positive regulation of chemokine production (GO:0032722) | 2.90661038 |
115 | negative thymic T cell selection (GO:0045060) | 2.89403076 |
116 | T cell migration (GO:0072678) | 2.89247314 |
117 | positive regulation of interleukin-12 production (GO:0032735) | 2.88177402 |
118 | regulation of cholesterol storage (GO:0010885) | 2.87676558 |
119 | dendritic cell migration (GO:0036336) | 2.86964159 |
120 | positive regulation of tolerance induction (GO:0002645) | 2.86870540 |
121 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.86179287 |
122 | regulation of regulated secretory pathway (GO:1903305) | 2.85086624 |
123 | dendritic cell differentiation (GO:0097028) | 2.84408837 |
124 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.84373843 |
125 | negative regulation of cell killing (GO:0031342) | 2.84227599 |
126 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.84227599 |
127 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.82553341 |
128 | dendritic cell chemotaxis (GO:0002407) | 2.82396228 |
129 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.82374073 |
130 | response to protozoan (GO:0001562) | 2.82221159 |
131 | negative T cell selection (GO:0043383) | 2.81825514 |
132 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.81779881 |
133 | cellular response to interferon-beta (GO:0035458) | 2.81762123 |
134 | negative regulation of interleukin-12 production (GO:0032695) | 2.81488436 |
135 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.81262181 |
136 | neutrophil mediated immunity (GO:0002446) | 2.81134475 |
137 | glycosphingolipid catabolic process (GO:0046479) | 2.81039929 |
138 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.80327252 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.31748416 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.14658795 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.94126172 |
4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 5.04777349 |
5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.49556757 |
6 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.99141695 |
7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.95431863 |
8 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.80219119 |
9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.72622054 |
10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.48520073 |
11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.33631295 |
12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.91876222 |
13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.83724616 |
14 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.78622863 |
15 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.67170233 |
16 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.57741792 |
17 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.55424640 |
18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.48583261 |
19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.33692588 |
20 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.20367638 |
21 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.18612566 |
22 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.15871850 |
23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.04147252 |
24 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.99641805 |
25 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.89778637 |
26 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.88861116 |
27 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.84844416 |
28 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.83003891 |
29 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.80943361 |
30 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.77701831 |
31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.76156854 |
32 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.70641461 |
33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.69476790 |
34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.68997525 |
35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.68373017 |
36 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.65665060 |
37 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.64997612 |
38 | MYB_26560356_Chip-Seq_TH2_Human | 1.63667263 |
39 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60556643 |
40 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.56507376 |
41 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.51975860 |
42 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.46646810 |
43 | MYC_22102868_ChIP-Seq_BL_Human | 1.44249286 |
44 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.44058657 |
45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39059630 |
46 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37898663 |
47 | MAF_26560356_Chip-Seq_TH1_Human | 1.36023216 |
48 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.30117971 |
49 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29192369 |
50 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.25562783 |
51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23124474 |
52 | MYB_26560356_Chip-Seq_TH1_Human | 1.22357713 |
53 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.21279693 |
54 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20842850 |
55 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.20147912 |
56 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19907016 |
57 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.18236225 |
58 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.16404388 |
59 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15496864 |
60 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.15027498 |
61 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.13211028 |
62 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.12230750 |
63 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11613547 |
64 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08912934 |
65 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05101828 |
66 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.01463864 |
67 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00599861 |
68 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.97439897 |
69 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.96607201 |
70 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.96599055 |
71 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95385909 |
72 | GATA1_22025678_ChIP-Seq_K562_Human | 0.93975422 |
73 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92741492 |
74 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.92429383 |
75 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92366746 |
76 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88618024 |
77 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.88415759 |
78 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.88298855 |
79 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.87587842 |
80 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.87587842 |
81 | UTX_26944678_Chip-Seq_JUKART_Human | 0.87286854 |
82 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.87124826 |
83 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.83697868 |
84 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.82811080 |
85 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.81294071 |
86 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.79654507 |
87 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.79051063 |
88 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.79015531 |
89 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.77418670 |
90 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.77057086 |
91 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.74603426 |
92 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.74192332 |
93 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73970668 |
94 | GATA2_19941826_ChIP-Seq_K562_Human | 0.73000812 |
95 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.72530509 |
96 | CJUN_26792858_Chip-Seq_BT549_Human | 0.71432425 |
97 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.71386928 |
98 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.70977803 |
99 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.70847602 |
100 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.70686781 |
101 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.70467771 |
102 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.70027417 |
103 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.69909626 |
104 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68411536 |
105 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67947449 |
106 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.66906201 |
107 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.65565139 |
108 | GATA1_19941826_ChIP-Seq_K562_Human | 0.65336171 |
109 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.64556148 |
110 | MAF_26560356_Chip-Seq_TH2_Human | 0.61471192 |
111 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.60958866 |
112 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.60558342 |
113 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.59523127 |
114 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.59294709 |
115 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.58358985 |
116 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.55498023 |
117 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.55420220 |
118 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.54549816 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * MP0001835_abnormal_antigen_presentation | 4.85270412 |
2 | MP0005058_abnormal_lysosome_morphology | 3.94255849 |
3 | MP0006082_CNS_inflammation | 3.89477488 |
4 | MP0002148_abnormal_hypersensitivity_rea | 3.64052873 |
5 | * MP0003436_decreased_susceptibility_to | 3.44526751 |
6 | MP0002419_abnormal_innate_immunity | 3.44395133 |
7 | MP0003303_peritoneal_inflammation | 3.35015439 |
8 | MP0009785_altered_susceptibility_to | 3.22256886 |
9 | * MP0005000_abnormal_immune_tolerance | 3.18845533 |
10 | MP0005025_abnormal_response_to | 2.91921091 |
11 | * MP0002452_abnormal_antigen_presenting | 2.78210959 |
12 | MP0003172_abnormal_lysosome_physiology | 2.78209247 |
13 | MP0003191_abnormal_cellular_cholesterol | 2.76378366 |
14 | MP0005671_abnormal_response_to | 2.75630685 |
15 | MP0005387_immune_system_phenotype | 2.71399576 |
16 | MP0001790_abnormal_immune_system | 2.71399576 |
17 | MP0003724_increased_susceptibility_to | 2.70581884 |
18 | * MP0002723_abnormal_immune_serum | 2.53038873 |
19 | * MP0001800_abnormal_humoral_immune | 2.47724310 |
20 | MP0000685_abnormal_immune_system | 2.42216107 |
21 | MP0004510_myositis | 2.40548073 |
22 | MP0005464_abnormal_platelet_physiology | 2.30378490 |
23 | * MP0001819_abnormal_immune_cell | 2.28842434 |
24 | * MP0002420_abnormal_adaptive_immunity | 2.25676707 |
25 | MP0003075_altered_response_to | 2.02803908 |
26 | * MP0001533_abnormal_skeleton_physiology | 1.97316511 |
27 | MP0002405_respiratory_system_inflammati | 1.90666818 |
28 | MP0003690_abnormal_glial_cell | 1.90232150 |
29 | * MP0001845_abnormal_inflammatory_respons | 1.87442202 |
30 | MP0001853_heart_inflammation | 1.85985822 |
31 | MP0009840_abnormal_foam_cell | 1.85726691 |
32 | MP0000343_altered_response_to | 1.83614086 |
33 | MP0005451_abnormal_body_composition | 1.78516030 |
34 | MP0008469_abnormal_protein_level | 1.71163054 |
35 | MP0002998_abnormal_bone_remodeling | 1.70666706 |
36 | MP0004947_skin_inflammation | 1.69667261 |
37 | MP0003448_altered_tumor_morphology | 1.68614744 |
38 | MP0000604_amyloidosis | 1.66130563 |
39 | MP0009764_decreased_sensitivity_to | 1.61113898 |
40 | MP0005166_decreased_susceptibility_to | 1.60289433 |
41 | MP0000716_abnormal_immune_system | 1.59534006 |
42 | MP0000569_abnormal_digit_pigmentation | 1.50260220 |
43 | MP0010155_abnormal_intestine_physiology | 1.47017075 |
44 | MP0002132_abnormal_respiratory_system | 1.45202998 |
45 | MP0009333_abnormal_splenocyte_physiolog | 1.43361943 |
46 | MP0005167_abnormal_blood-brain_barrier | 1.41384710 |
47 | MP0002398_abnormal_bone_marrow | 1.39651265 |
48 | MP0002006_tumorigenesis | 1.38016411 |
49 | MP0003183_abnormal_peptide_metabolism | 1.33428970 |
50 | * MP0005310_abnormal_salivary_gland | 1.32131612 |
51 | MP0003300_gastrointestinal_ulcer | 1.29116001 |
52 | MP0000689_abnormal_spleen_morphology | 1.28792982 |
53 | MP0000858_altered_metastatic_potential | 1.27843424 |
54 | MP0002277_abnormal_respiratory_mucosa | 1.26329030 |
55 | MP0002429_abnormal_blood_cell | 1.24915216 |
56 | MP0004782_abnormal_surfactant_physiolog | 1.24627159 |
57 | MP0002254_reproductive_system_inflammat | 1.15481962 |
58 | MP0002166_altered_tumor_susceptibility | 1.14748624 |
59 | MP0001851_eye_inflammation | 1.12928586 |
60 | MP0002722_abnormal_immune_system | 1.11553542 |
61 | MP0003828_pulmonary_edema | 1.09391279 |
62 | MP0005257_abnormal_intraocular_pressure | 1.09136055 |
63 | MP0009278_abnormal_bone_marrow | 1.07963799 |
64 | MP0000703_abnormal_thymus_morphology | 1.06107050 |
65 | MP0004381_abnormal_hair_follicle | 1.04441477 |
66 | MP0005164_abnormal_response_to | 1.01948787 |
67 | MP0008004_abnormal_stomach_pH | 1.00960983 |
68 | MP0010307_abnormal_tumor_latency | 0.99858032 |
69 | MP0005174_abnormal_tail_pigmentation | 0.98055971 |
70 | MP0002090_abnormal_vision | 0.96859533 |
71 | MP0002933_joint_inflammation | 0.95626911 |
72 | MP0001545_abnormal_hematopoietic_system | 0.91312408 |
73 | MP0005397_hematopoietic_system_phenotyp | 0.91312408 |
74 | MP0009763_increased_sensitivity_to | 0.90977897 |
75 | MP0000920_abnormal_myelination | 0.89773674 |
76 | MP0003329_amyloid_beta_deposits | 0.89756502 |
77 | MP0000465_gastrointestinal_hemorrhage | 0.89680218 |
78 | MP0003806_abnormal_nucleotide_metabolis | 0.88630680 |
79 | * MP0005390_skeleton_phenotype | 0.88529424 |
80 | MP0000249_abnormal_blood_vessel | 0.85340972 |
81 | MP0003566_abnormal_cell_adhesion | 0.85269763 |
82 | MP0002396_abnormal_hematopoietic_system | 0.84311494 |
83 | MP0004883_abnormal_blood_vessel | 0.82368504 |
84 | MP0005076_abnormal_cell_differentiation | 0.81836087 |
85 | MP0008260_abnormal_autophagy | 0.81589547 |
86 | MP0003186_abnormal_redox_activity | 0.81107555 |
87 | MP0010386_abnormal_urinary_bladder | 0.78707482 |
88 | MP0002138_abnormal_hepatobiliary_system | 0.77296860 |
89 | MP0006054_spinal_hemorrhage | 0.76713049 |
90 | MP0003795_abnormal_bone_structure | 0.76660654 |
91 | MP0002136_abnormal_kidney_physiology | 0.72235049 |
92 | MP0000371_diluted_coat_color | 0.71749514 |
93 | MP0003656_abnormal_erythrocyte_physiolo | 0.69633271 |
94 | MP0002332_abnormal_exercise_endurance | 0.67409607 |
95 | MP0009765_abnormal_xenobiotic_induced | 0.66831654 |
96 | MP0005075_abnormal_melanosome_morpholog | 0.65823204 |
97 | MP0003221_abnormal_cardiomyocyte_apopto | 0.65754906 |
98 | MP0004808_abnormal_hematopoietic_stem | 0.65561841 |
99 | MP0008874_decreased_physiological_sensi | 0.63281652 |
100 | MP0000767_abnormal_smooth_muscle | 0.62913877 |
101 | MP0000015_abnormal_ear_pigmentation | 0.60974757 |
102 | MP0008873_increased_physiological_sensi | 0.58778501 |
103 | MP0001873_stomach_inflammation | 0.58643368 |
104 | MP0003045_fibrosis | 0.57850118 |
105 | MP0002009_preneoplasia | 0.56526823 |
106 | MP0003453_abnormal_keratinocyte_physiol | 0.56412184 |
107 | MP0003091_abnormal_cell_migration | 0.55761122 |
108 | MP0002133_abnormal_respiratory_system | 0.54554685 |
109 | MP0005388_respiratory_system_phenotype | 0.54554685 |
110 | MP0005319_abnormal_enzyme/_coenzyme | 0.52792316 |
111 | MP0000490_abnormal_crypts_of | 0.52293567 |
112 | MP0003866_abnormal_defecation | 0.51956498 |
113 | MP0001663_abnormal_digestive_system | 0.50411954 |
114 | MP0000609_abnormal_liver_physiology | 0.49827050 |
115 | MP0003763_abnormal_thymus_physiology | 0.49731985 |
116 | MP0008438_abnormal_cutaneous_collagen | 0.49645179 |
117 | MP0005165_increased_susceptibility_to | 0.48132524 |
118 | MP0004130_abnormal_muscle_cell | 0.46999292 |
119 | MP0003634_abnormal_glial_cell | 0.46178040 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 7.66520118 |
2 | Eczematoid dermatitis (HP:0000976) | 7.07783757 |
3 | Recurrent bacterial skin infections (HP:0005406) | 6.96621454 |
4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.38680584 |
5 | Systemic lupus erythematosus (HP:0002725) | 5.84193196 |
6 | Increased cerebral lipofuscin (HP:0011813) | 5.32230027 |
7 | Abnormality of macrophages (HP:0004311) | 5.28871455 |
8 | Vacuolated lymphocytes (HP:0001922) | 5.10826405 |
9 | Abnormality of glycolipid metabolism (HP:0010969) | 4.84248489 |
10 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.84248489 |
11 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.84248489 |
12 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.80983351 |
13 | Mediastinal lymphadenopathy (HP:0100721) | 4.47067507 |
14 | Glomerulonephritis (HP:0000099) | 4.36161477 |
15 | Axonal loss (HP:0003447) | 4.30470927 |
16 | Recurrent skin infections (HP:0001581) | 4.29633628 |
17 | Disinhibition (HP:0000734) | 4.26565563 |
18 | Gingivitis (HP:0000230) | 4.15143047 |
19 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.94334048 |
20 | Chronic obstructive pulmonary disease (HP:0006510) | 3.91488664 |
21 | Obstructive lung disease (HP:0006536) | 3.91488664 |
22 | Autoimmune thrombocytopenia (HP:0001973) | 3.88124469 |
23 | Dysostosis multiplex (HP:0000943) | 3.83427481 |
24 | Gastrointestinal infarctions (HP:0005244) | 3.81235069 |
25 | Myositis (HP:0100614) | 3.63918768 |
26 | Recurrent fungal infections (HP:0002841) | 3.60744922 |
27 | Agnosia (HP:0010524) | 3.52149743 |
28 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.47072316 |
29 | T lymphocytopenia (HP:0005403) | 3.45931074 |
30 | Orchitis (HP:0100796) | 3.38843105 |
31 | Keratoconjunctivitis (HP:0001096) | 3.36753071 |
32 | Encephalitis (HP:0002383) | 3.28603875 |
33 | Abnormality of T cell number (HP:0011839) | 3.27266388 |
34 | Retrobulbar optic neuritis (HP:0100654) | 3.22805318 |
35 | Optic neuritis (HP:0100653) | 3.22805318 |
36 | Stomatitis (HP:0010280) | 3.22025395 |
37 | Basal ganglia calcification (HP:0002135) | 3.19528727 |
38 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.10880631 |
39 | Thick nail (HP:0001805) | 3.06354070 |
40 | Cellulitis (HP:0100658) | 3.03580465 |
41 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.02542087 |
42 | Mucopolysacchariduria (HP:0008155) | 3.02542087 |
43 | Pustule (HP:0200039) | 2.98257070 |
44 | Prostate neoplasm (HP:0100787) | 2.95831345 |
45 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.91019666 |
46 | Recurrent cutaneous fungal infections (HP:0011370) | 2.91019666 |
47 | Recurrent viral infections (HP:0004429) | 2.88382265 |
48 | Periodontitis (HP:0000704) | 2.87798431 |
49 | Chest pain (HP:0100749) | 2.85761475 |
50 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.84813957 |
51 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.84813957 |
52 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.84813957 |
53 | Vasculitis (HP:0002633) | 2.83595557 |
54 | Upper motor neuron abnormality (HP:0002127) | 2.78947659 |
55 | Interstitial pulmonary disease (HP:0006530) | 2.77822398 |
56 | Myocardial infarction (HP:0001658) | 2.76450404 |
57 | Recurrent pneumonia (HP:0006532) | 2.73602492 |
58 | Nephritis (HP:0000123) | 2.72803880 |
59 | Hepatosplenomegaly (HP:0001433) | 2.70242232 |
60 | Loss of speech (HP:0002371) | 2.69149115 |
61 | Urticaria (HP:0001025) | 2.68214468 |
62 | Hematochezia (HP:0002573) | 2.64734429 |
63 | Complement deficiency (HP:0004431) | 2.64125913 |
64 | Pulmonary embolism (HP:0002204) | 2.59434916 |
65 | Prolonged bleeding time (HP:0003010) | 2.58078948 |
66 | Abnormality of complement system (HP:0005339) | 2.57635909 |
67 | Osteomyelitis (HP:0002754) | 2.55751702 |
68 | Meningitis (HP:0001287) | 2.54961414 |
69 | Episodic fever (HP:0001954) | 2.54237342 |
70 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.54181537 |
71 | Increased IgE level (HP:0003212) | 2.52907248 |
72 | Anorexia (HP:0002039) | 2.47622927 |
73 | Peritonitis (HP:0002586) | 2.46826743 |
74 | Gangrene (HP:0100758) | 2.45488952 |
75 | Epistaxis (HP:0000421) | 2.43955184 |
76 | Pathologic fracture (HP:0002756) | 2.42721268 |
77 | Abnormality of T cells (HP:0002843) | 2.42691692 |
78 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.41789376 |
79 | Pulmonary infiltrates (HP:0002113) | 2.37814980 |
80 | Increased IgM level (HP:0003496) | 2.34043571 |
81 | Recurrent lower respiratory tract infections (HP:0002783) | 2.28093486 |
82 | Inappropriate behavior (HP:0000719) | 2.25354131 |
83 | Colitis (HP:0002583) | 2.23777470 |
84 | Abnormality of the pleura (HP:0002103) | 2.22653005 |
85 | Retinal atrophy (HP:0001105) | 2.22136707 |
86 | Leukocytosis (HP:0001974) | 2.20947176 |
87 | Tetraparesis (HP:0002273) | 2.19149702 |
88 | Osteolytic defects of the hand bones (HP:0009699) | 2.18957636 |
89 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.18957636 |
90 | Bone pain (HP:0002653) | 2.17501844 |
91 | Polyneuropathy (HP:0001271) | 2.16431647 |
92 | Increased serum ferritin (HP:0003281) | 2.14195084 |
93 | Vertigo (HP:0002321) | 2.13656147 |
94 | Mutism (HP:0002300) | 2.13264466 |
95 | Joint hemorrhage (HP:0005261) | 2.13068187 |
96 | Arterial thrombosis (HP:0004420) | 2.12833698 |
97 | Progressive visual loss (HP:0000529) | 2.10993893 |
98 | Spontaneous hematomas (HP:0007420) | 2.10693452 |
99 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.10096711 |
100 | Petechiae (HP:0000967) | 2.09683495 |
101 | Glomerulopathy (HP:0100820) | 2.08008742 |
102 | Peripheral demyelination (HP:0011096) | 2.07767620 |
103 | Premature loss of primary teeth (HP:0006323) | 2.07736791 |
104 | Hemoptysis (HP:0002105) | 2.06135822 |
105 | Amaurosis fugax (HP:0100576) | 2.05568702 |
106 | Diminished motivation (HP:0000745) | 2.05317641 |
107 | Abnormality of the endocardium (HP:0004306) | 2.05226060 |
108 | Apathy (HP:0000741) | 2.05221270 |
109 | Hypergammaglobulinemia (HP:0010702) | 2.02728862 |
110 | Abnormality of the peritoneum (HP:0002585) | 2.02206620 |
111 | Granulocytopenia (HP:0001913) | 2.02181436 |
112 | Inflammation of the large intestine (HP:0002037) | 2.00390399 |
113 | Panhypogammaglobulinemia (HP:0003139) | 1.95903133 |
114 | Chronic otitis media (HP:0000389) | 1.94853868 |
115 | Abnormality of iron homeostasis (HP:0011031) | 1.90371866 |
116 | Malnutrition (HP:0004395) | 1.89525397 |
117 | Poor head control (HP:0002421) | 1.88661564 |
118 | Cheilitis (HP:0100825) | 1.88167833 |
119 | Gingival bleeding (HP:0000225) | 1.87841318 |
120 | Acne (HP:0001061) | 1.87353090 |
121 | Viral hepatitis (HP:0006562) | 1.85879541 |
122 | Sepsis (HP:0100806) | 1.84960503 |
123 | Purpura (HP:0000979) | 1.84352918 |
124 | Slow saccadic eye movements (HP:0000514) | 1.83768832 |
125 | J-shaped sella turcica (HP:0002680) | 1.82961438 |
126 | Skin ulcer (HP:0200042) | 1.82373193 |
127 | Recurrent bronchitis (HP:0002837) | 1.81447330 |
128 | Gastrointestinal inflammation (HP:0004386) | 1.81050391 |
129 | Personality changes (HP:0000751) | 1.79880874 |
130 | Amyloidosis (HP:0011034) | 1.79378905 |
131 | Keratoconjunctivitis sicca (HP:0001097) | 1.77848342 |
132 | Eosinophilia (HP:0001880) | 1.75542423 |
133 | Abnormality of the lumbar spine (HP:0100712) | 1.75233751 |
134 | Conjunctival telangiectasia (HP:0000524) | 1.74325366 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 4.77944144 |
2 | BLK | 3.94239839 |
3 | MAP3K14 | 3.78197340 |
4 | TBK1 | 3.32588861 |
5 | TYK2 | 3.31706784 |
6 | IRAK4 | 3.23503353 |
7 | TGFBR2 | 3.17885124 |
8 | PBK | 2.85673819 |
9 | IRAK3 | 2.67745657 |
10 | KIT | 2.55068421 |
11 | MAP4K1 | 2.51034807 |
12 | PRPF4B | 2.45822929 |
13 | IKBKE | 2.25772358 |
14 | IKBKB | 2.19482642 |
15 | JAK1 | 2.09673762 |
16 | CSF1R | 2.09398026 |
17 | GRK7 | 1.96375460 |
18 | TXK | 1.88189259 |
19 | JAK3 | 1.87847715 |
20 | ERN1 | 1.72899357 |
21 | NEK9 | 1.70887485 |
22 | MAP3K13 | 1.66671920 |
23 | CSK | 1.61045069 |
24 | SYK | 1.57544276 |
25 | ZAP70 | 1.50125946 |
26 | HCK | 1.48496236 |
27 | TNK2 | 1.44480412 |
28 | TAOK1 | 1.43502183 |
29 | LYN | 1.40873858 |
30 | PIM2 | 1.37710230 |
31 | MAP3K1 | 1.30188829 |
32 | FGR | 1.26547192 |
33 | NME2 | 1.26319389 |
34 | JAK2 | 1.21172367 |
35 | MATK | 1.20473554 |
36 | LCK | 1.19692062 |
37 | KSR2 | 1.17255232 |
38 | STK10 | 1.14510485 |
39 | TAOK3 | 1.13940661 |
40 | CHUK | 1.11933757 |
41 | BTK | 1.11028337 |
42 | FES | 1.09249409 |
43 | MST4 | 1.04078400 |
44 | ABL2 | 1.01566783 |
45 | BMPR2 | 1.00433685 |
46 | MAP3K2 | 0.99677575 |
47 | TEC | 0.97285371 |
48 | MST1R | 0.97182363 |
49 | MARK3 | 0.96801853 |
50 | ITK | 0.93998154 |
51 | EPHB1 | 0.93778651 |
52 | ARAF | 0.92338163 |
53 | TAOK2 | 0.89148743 |
54 | RIPK1 | 0.88085408 |
55 | RPS6KA4 | 0.87780461 |
56 | PIM1 | 0.87639065 |
57 | MOS | 0.86879401 |
58 | BMX | 0.86759399 |
59 | ACVR1B | 0.86621189 |
60 | CAMK1D | 0.83947083 |
61 | CLK1 | 0.82773445 |
62 | PDK2 | 0.79778911 |
63 | PRKCD | 0.79510829 |
64 | YES1 | 0.79472475 |
65 | TRPM7 | 0.77391388 |
66 | MARK2 | 0.77161293 |
67 | FGFR3 | 0.76775228 |
68 | ADRBK2 | 0.75742514 |
69 | MAP2K3 | 0.75404420 |
70 | EGFR | 0.73605238 |
71 | MAP3K6 | 0.73417979 |
72 | ABL1 | 0.70285606 |
73 | FGFR4 | 0.69692836 |
74 | CDC42BPA | 0.69395128 |
75 | STK4 | 0.65494018 |
76 | MAPK7 | 0.63734583 |
77 | SGK3 | 0.62776169 |
78 | SCYL2 | 0.61507339 |
79 | ERBB3 | 0.59149531 |
80 | EIF2AK2 | 0.58454693 |
81 | TESK2 | 0.58011125 |
82 | IRAK2 | 0.55184224 |
83 | SIK2 | 0.54894397 |
84 | MAP3K10 | 0.54197391 |
85 | PAK4 | 0.53260883 |
86 | PDK1 | 0.52906752 |
87 | KSR1 | 0.51195065 |
88 | CAMKK2 | 0.50020916 |
89 | SGK2 | 0.49500390 |
90 | CDK19 | 0.48904745 |
91 | DYRK1B | 0.44752202 |
92 | PDPK1 | 0.44716018 |
93 | PRKCQ | 0.44673244 |
94 | FYN | 0.44374370 |
95 | PTK2B | 0.44364544 |
96 | IRAK1 | 0.43553566 |
97 | NLK | 0.43050593 |
98 | RAF1 | 0.42643171 |
99 | MAP2K4 | 0.42530151 |
100 | LRRK2 | 0.42346910 |
101 | IGF1R | 0.41894043 |
102 | RPS6KC1 | 0.40898537 |
103 | RPS6KL1 | 0.40898537 |
104 | MAPKAPK2 | 0.40629018 |
105 | DAPK2 | 0.40540799 |
106 | STK11 | 0.40400744 |
107 | PRKD2 | 0.40238519 |
108 | TRIB3 | 0.39071516 |
109 | MAP2K6 | 0.37379188 |
110 | HIPK2 | 0.37337120 |
111 | TTN | 0.37059849 |
112 | MAPK15 | 0.36745300 |
113 | MAP3K3 | 0.36278426 |
114 | CDK6 | 0.35987247 |
115 | CAMKK1 | 0.35437414 |
116 | PTK6 | 0.34508182 |
117 | RET | 0.34172134 |
118 | MAP3K7 | 0.33321486 |
119 | PIK3CG | 0.31832575 |
120 | CAMK1G | 0.31461871 |
121 | PDGFRB | 0.31411020 |
122 | MAPK12 | 0.30082950 |
123 | SIK3 | 0.29630688 |
124 | MAP3K5 | 0.29111762 |
125 | EPHA3 | 0.28692940 |
126 | MAP3K11 | 0.28439543 |
127 | INSR | 0.27132680 |
128 | PKN2 | 0.26865359 |
129 | RPS6KA6 | 0.25587036 |
130 | GRK6 | 0.24626914 |
131 | STK3 | 0.23845401 |
132 | PRKCH | 0.21520431 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.99904137 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.36681586 |
3 | * Lysosome_Homo sapiens_hsa04142 | 2.95007150 |
4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.76077644 |
5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.73671430 |
6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.63167096 |
7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.52735788 |
8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.49918749 |
9 | Pertussis_Homo sapiens_hsa05133 | 2.44467536 |
10 | Legionellosis_Homo sapiens_hsa05134 | 2.35719781 |
11 | * Tuberculosis_Homo sapiens_hsa05152 | 2.34134835 |
12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.30882332 |
13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.23321332 |
14 | Malaria_Homo sapiens_hsa05144 | 2.07905802 |
15 | * Phagosome_Homo sapiens_hsa04145 | 2.06717893 |
16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.97084325 |
17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.95151387 |
18 | Allograft rejection_Homo sapiens_hsa05330 | 1.86310459 |
19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.86123677 |
20 | Measles_Homo sapiens_hsa05162 | 1.84197686 |
21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.79870088 |
22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.74642716 |
23 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.74200278 |
24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.73010682 |
25 | Salmonella infection_Homo sapiens_hsa05132 | 1.70774910 |
26 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.66233282 |
27 | Influenza A_Homo sapiens_hsa05164 | 1.57212077 |
28 | Asthma_Homo sapiens_hsa05310 | 1.55389343 |
29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.52833402 |
30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.46188135 |
31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.45309632 |
32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.44187008 |
33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.42454966 |
34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.41955322 |
35 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 1.40322595 |
36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.32980236 |
37 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.32861612 |
38 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.25706221 |
39 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.24390821 |
40 | * Apoptosis_Homo sapiens_hsa04210 | 1.22309477 |
41 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.21487533 |
42 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.18521078 |
43 | Shigellosis_Homo sapiens_hsa05131 | 1.17322544 |
44 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.16750765 |
45 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.10419980 |
46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.06398705 |
47 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.06091840 |
48 | Prion diseases_Homo sapiens_hsa05020 | 1.04324606 |
49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.97704092 |
50 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.94917233 |
51 | Viral myocarditis_Homo sapiens_hsa05416 | 0.94618489 |
52 | Hepatitis B_Homo sapiens_hsa05161 | 0.94527707 |
53 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.91949891 |
54 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.90380079 |
55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88731462 |
56 | Hepatitis C_Homo sapiens_hsa05160 | 0.83086098 |
57 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.81659808 |
58 | Amoebiasis_Homo sapiens_hsa05146 | 0.81496259 |
59 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.75848432 |
60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.75181829 |
61 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.74259439 |
62 | Platelet activation_Homo sapiens_hsa04611 | 0.70519743 |
63 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.64033536 |
64 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57781130 |
65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55728046 |
66 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54882823 |
67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.54425838 |
68 | Mineral absorption_Homo sapiens_hsa04978 | 0.53832191 |
69 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.53774505 |
70 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53323919 |
71 | Endocytosis_Homo sapiens_hsa04144 | 0.52754713 |
72 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.51186103 |
73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50399367 |
74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.50070315 |
75 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.48337221 |
76 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44687807 |
77 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.44417606 |
78 | Endometrial cancer_Homo sapiens_hsa05213 | 0.43999494 |
79 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.42133928 |
80 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.40895882 |
81 | Insulin resistance_Homo sapiens_hsa04931 | 0.40300336 |
82 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39941391 |
83 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.39750207 |
84 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39523479 |
85 | HTLV-I infection_Homo sapiens_hsa05166 | 0.39231401 |
86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38800558 |
87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.37972827 |
88 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37646600 |
89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35923783 |
90 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35502154 |
91 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34664138 |
92 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.31388328 |
93 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.30533473 |
94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.30185128 |
95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30125402 |
96 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.27839744 |
97 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.27820492 |
98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.26252367 |
99 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.25857004 |
100 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.25506418 |
101 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.25299849 |
102 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.25280016 |
103 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.24891520 |
104 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.23556734 |
105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.22702406 |
106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.22640195 |
107 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.21507826 |
108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.21505933 |
109 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.18841241 |
110 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.18316839 |
111 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.17100542 |
112 | Adherens junction_Homo sapiens_hsa04520 | 0.13882028 |
113 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.12286253 |
114 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.11566719 |
115 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.11467793 |